Sufentanil citrate is a synthetic analgesic drug and primarily finds its application in inducing anesthesia during surgery. Sufentanil citrate is also used as epidural anesthesia during labor and delivery along with various other medicines. Sufentanil citrate is typically white in color and used in powdered form. Sufentanil citrate demonstrates high solubility in both water as well as alcohol. Sufentanil citrate is 2000 to 4000 times as potent as morphine, making sufentanil citrate highly narcotic. Considering, the potential usage in medicinal application, the Sufentanil Citrate Market is expected to increase. The market for sufentanil citrate injections is majorly dominated by developed regions such as North America, chiefly followed by Europe. The major reason for this dominance is the penchant for advanced technologies. Asia Pacific region and other developing regions are expected to be the upcoming markets for sufentanil citrate injections.

Sufentanil citrate shows very high potent compared to its other counterparts such as fentanyl. However, the sufentanil citrate demonstrates instantaneous action, with comparably limited body accumulation. This property of sufentanil citrate makes it highly important in anesthetic use for medical field. Accelerated removal of sufentanil citrate from body allows faster recovery of patients when compared to equipotent prescription of fentanyl.

Approximately 80% of the administered dose is excreted within 24 hours and only 2% of the dose is eliminated as unchanged drug. Moreover, sufentanil citrate has low cardiovascular toxicity, making it apposite as total intravenous anesthetic for surgical procedures and finds particular utility for open heart surgery and other severe cardiovascular surgeries. However, sufentanil citrate demonstrates high potential for overdependence similar to morphine drug, therefore has the latent for being abused. Furthermore, when sufentanil citrate is administered in combination with volatile inhalational agents, it increases respiratory depression. Taking into account the probable threats associated with respiratory depression, necessary precaution and monitoring should be done for the patients.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3764

Presently, the sufentanil citrate market is dominated by developed regions such as the U.S. and Europe majorly due to availability of advanced medical technologies. The increase in number of medical surgeries is expected to propel the growth of sufentanil citrate market. The augmentation in cardiovascular diseases and associated surgeries is expected to boost the requirement for sufentanil citrate in next few years. Also, the increase in gynecological surgeries is expected to increase the requirement of sufentanil citrate, thus increasing its market growth rate. Moreover, the faster removal of sufentanil citrate from body acts as a potential benefit for faster recovery of patients when compared with other drugs. The market for sufentanil citrate in form of intravenous injection dosages is expected to increase in eastern countries in next six years considering the potential benefits of sufentanil citrate.

Asia Pacific countries such as China, India, Thailand, Indonesia and other developing countries in RoW are anticipated to be the upcoming market for sufentanil citrate. In spite of limited accumulation of sufentanil citrate in body, the drug demonstrates certain drawbacks such as respiratory depression. Moreover, the potential of sufentanil citrate to be used as abuse is expected to certainly affect the market of sufentanil citrate in developed regions, increasing the usage regulations on it. Gradual improvement in medicinal usage and additional safety regulations is expected to increase the demand for sufentanil citrate across developing regions.

Request to View ToC of the report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=3764

The potential applications of sufentanil citrate in medical sector would create a lucrative option for several companies to penetrate in sufentanil citrate market. Some of the key players dominant in sufentanil citrate industry include Akorn, Inc and Mallinckrodt Pharmaceuticals.